Alteration of enhancer of polycomb 1 at 10p11.2 is one of the genetic events leading to development of adult T-cell leukemia/lymphoma

Genes Chromosomes and Cancer

Volumn 48, Issue 9, 2009, Pages 768-776

  Nakahata, Shingo ^a   Saito, Yusuke ^a   Hamasaki, Makoto ^a   Hidaka, Tomonori ^a,b   Arai, Yasuhito ^c   Taki, Tomohiko ^d   Taniwaki, Masafumi ^d   Morishita, Kazuhiro ^a  

^a UNIVERSITY OF MIYAZAKI   (Japan)

^b UNIVERSITY OF MIYAZAKI   (Japan)

^c NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^d KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

POLYCOMB GROUP PROTEIN;

AMINO ACID SEQUENCE; ARTICLE; CANCER GROWTH; CHROMOSOME 10P; CHROMOSOME 10Q; CHROMOSOME 2P; CHROMOSOME BREAKAGE; CHROMOSOME DELETION; CHROMOSOME TRANSLOCATION 10; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; ENHANCER REGION; EPC1 GENE; GENE IDENTIFICATION; GENE LOCUS; GENE OVEREXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; LEUKEMOGENESIS; MALIGNANT TRANSFORMATION; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; T CELL LEUKEMIA;

ADULT; CD4-POSITIVE T-LYMPHOCYTES; CELL LINE, TUMOR; CELL PROLIFERATION; CELLS, CULTURED; CHROMOSOMAL PROTEINS, NON-HISTONE; CHROMOSOME BREAKAGE; CHROMOSOMES, HUMAN, PAIR 10; COMPARATIVE GENOMIC HYBRIDIZATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LEUKEMIA-LYMPHOMA, ADULT T-CELL; MUTANT CHIMERIC PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REPRESSOR PROTEINS; TRANSCRIPTION, GENETIC; TRANSLOCATION, GENETIC;

HUMAN T-LYMPHOTROPIC VIRUS 1;

EID: 68549132635     PISSN: 10452257     EISSN: 10982264     Source Type: Journal    
DOI: 10.1002/gcc.20681     Document Type: Article

References (24)

1. Attwooll C, Oddi S, Cartwright P, Prosperini E, Agger K, Steensgaard P, Wagener C, Sardet C, Moroni MC, Helin K. 2005. A novel repressive E2F6 complex containing the polycomb group protein, EPC1, that interacts with EZH2 in a proliferationspecific manner. J Biol Chem 280:1199-1208.
2. Doyon Y, Selleck W, Lane WS, Tan S, Côté J. 2004. Structural and functional conservation of the NuA4 histone acetyltransferase complex from yeast to humans. Mol Cell Biol 24:1884-1896.
3. Fisher CL, Randazzo F, Humphries RK, Brock HW. 2006. Characterization of Asxl1, a murine homolog of Additional sex combs, and analysis of the Asx-like gene family. Gene 369:109-118.
4. Gillis S, Smith KA. 1977. Long term culture of tumour-specific cytotoxic T cells. Nature 268:154-156.
5. Hidaka T, Nakahata S, Hatakeyama K, Hamasaki M, Yamashita K, Kohno T, Arai Y, Taki T, Nishida K, Okayama A, Asada Y, Yamaguchi R, Tsubouchi H, Yokota J, Taniwaki M, Higashi Y, Morishita K. 2008. Down-regulation of TCF8 is involved in the leukemogenesis of adult-T cell leukemia/lymphoma. Blood 112:383-393.
6. Hosoda F, Kitabayashi I, Kakazu N, Fukushima M, Aikawa Y, Abe T, Hibi S, Yagi T, Ohki M. 2002. MOZ Is fused to a novel Polycomb group gene in a therapy-related myelodysplastic syndrome with t(2;8)(p23;p11.2). Submitted (APR-2002) to the EMBL/GenBank/DDBJ databases (Database: UniProt, Entry: Q92794).
7. Koontz JI, Soreng AL, Nucci M, Kuo FC, Pauwels P, van Den Berghe H, Dal Cin P, Fletcher JA, Sklar J. 2001. Frequent fusion of the JAZF1 and JJAZ1 genes in endometrial stromal tumors. Proc Natl Acad Sci USA 98:6348-6353.
8. Katoh M, Katoh M. 2003. Identification and characterization of ASXL2 gene in silico. Int J Oncol 23:845-850.
9. Mathew S, Head D, Rubnitz JE, Raimondi SC. 2000. Concurrent translocations of MLL and CBFA2 (AML1) genes with new partner breakpoints in a child with secondary myelodysplastic syndrome after treatment of acute lymphoblastic leukemia. Genes Chromosomes Cancer 28:227-232.
10. Micci F, Panagopoulos I, Bjerkehagen B, Heim S. 2006. Consistent rearrangement of chromosomal band 6p21 with generation of fusion genes JAZF1/PHF1 and EPC1/PHF1 in endometrial stromal sarcoma. Cancer Res 66:107-112.
11. Minowada J, Onuma T, Moore GE. 1972. Rosette-forming human lymphoid cell lines. I. Establishment and evidence for origin of thymus-derived lymphocytes. J Natl Cancer Inst 49:891-895.
12. Miyoshi I, Kubonishi I, Yoshimoto S, Akagi T, Ohtsuki Y, Shiraishi Y, Nagata K, Hinuma Y. 1981. Type C virus particles in a cord T-cell line derived by co-cultivating normal human cord leukocytes and human leukaemic T cells. Nature 294:770-771.
13. Nishikata I, Sasaki H, Iga M, Tateno Y, Imayoshi S, Asou N, Nakamura T, Morishita K. 2003. A novel EVI1 gene family, MEL1, lacking a PR domain (MEL1S) is expressed mainly in t(1;3)(p36;q21)-positive AML and blocks G-CSF-induced myeloid differentiation. Blood 102:3323-3332.
14. Okada M, Maeda M, Tagaya Y, Taniguchi Y, Teshigawara K, Yoshiki T, Diamantstein T, Smith KA, Uchiyama T, Honjo T. 1985. TCGF (IL 2)-receptor induction Factor (S). II. Possible role of ATL-derived factor (ADF) on constitutive IL 2 receptor expression of HTLV-1(+) T cell lines. J Immunol 135:3995-4003.
15. Okamoto T, Ohno Y, Tsugane S, Watanabe S, Shimoyama M, Tajima K, Miwa M, Shimotohno K. 1989. Multi-step carcinogenesis model for adult T-cell leukemia. Jpn J Cancer Res 80:191-195.
16. Raaphorst FM. 2005. Deregulated expression of Polycomb-group oncogenes in human malignant lymphomas and epithelial tumors. Hum Mol Genet 14: (Spec No 1)R93-R100.
17. Ramocki MB, Dowling J, Grinberg I, Kimonis VE, Cardoso C, Gross A, Chung J, Martin CL, Ledbetter DH, Dobyns WB, Millen KJ. 2003. Reciprocal fusion transcripts of two novel Zn-finger genes in a female with absence of the corpus callosum, ocular colobomas and a balanced translocation between chromosomes 2p24 and 9q32. Eur J Hum Genet 11:527-534.
18. Sarma K, Margueron R, Ivanov A, Pirrotta V, Reinberg D. 2008. Ezh2 requires PHF1 to efficiently catalyze H3 lysine 27 trimethylation in vivo. Mol Cell Biol 28:2718-2731.
19. Sasaki H, Nishikata I, Shiraga T, Akamatsu E, Fukami T, Hidaka T, Kubuki Y, Okayama A, Hamada K, Okabe H, Murakami Y, Tsubouchi H, Morishita K. 2005. Overexpression of a cell adhesion molecule, TSLC1, as a possible molecular marker for acute-type adult T-cell leukemia. Blood 105:1204-1213.
20. Schneider U, Schwenk HU, Bornkamm G. 1977. Characterization of EBV-genome negative "null" and "T" cell lines derived from children with acute lymphoblastic leukemia and leukemic transformed non-Hodgkin lymphoma. Int J Cancer 19:621-626.
21. Shimono Y, Murakami H, Hasegawa Y, Takahashi M. 2000. RET finger protein is a transcriptional repressor and interacts with enhancer of polycomb that has dual transcriptional functions. J Biol Chem 275:39411-39419.
22. Stankunas K, Berger J, Ruse C, Sinclair DA, Randazzo F, Brock HW. 1998. The enhancer of polycomb gene of Drosophila encodes a chromatin protein conserved in yeast and mammals. Development 125:4055-4066.
23. Tezel G, Shimono Y, Murakumo Y, Kawai K, Fukuda T, Iwahashi N, Takahashi M. 2002. Role for O-glycosylation of RFP in the interaction with enhancer of polycomb. Biochem Biophys Res Commun 290:409-414.
24. Yamada Y, Ohmoto Y, Hata T, Yamamura M, Murata K, Tsukasaki K, Kohno T, Chen Y, Kamihira S, Tomonaga M. 1996. Features of the cytokines secreted by adult T cell leukemia (ATL) cells. Leuk Lymphoma 21:443-447.